AbCellera Biologics Inc. (ABCL)

AbCellera Biologics Statistics

Total Valuation

ABCL has a market cap or net worth of $774.77 million. The enterprise value is $214.52 million.

Market Cap	774.77M
Enterprise Value	214.52M

Important Dates

The next confirmed earnings date is Thursday, May 8, 2025, after market close.

Earnings Date	May 8, 2025
Ex-Dividend Date	n/a

Share Statistics

ABCL has 297.99 million shares outstanding. The number of shares has increased by 1.79% in one year.

Current Share Class	297.99M
Shares Outstanding	297.99M
Shares Change (YoY)	+1.79%
Shares Change (QoQ)	+0.23%
Owned by Insiders (%)	22.71%
Owned by Institutions (%)	32.02%
Float	202.80M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	26.54
Forward PS	18.78
PB Ratio	0.73
P/TBV Ratio	0.80
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	7.44
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 9.81, with a Debt / Equity ratio of 0.06.

Current Ratio	9.81
Quick Ratio	8.95
Debt / Equity	0.06
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -14.75% and return on invested capital (ROIC) is -15.03%.

Return on Equity (ROE)	-14.75%
Return on Assets (ROA)	-12.41%
Return on Invested Capital (ROIC)	-15.03%
Return on Capital Employed (ROCE)	-22.02%
Revenue Per Employee	$48,378
Profits Per Employee	-$273,250
Employee Count	596
Asset Turnover	0.02
Inventory Turnover	n/a

Taxes

Income Tax	-37.54M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -34.89% in the last 52 weeks. The beta is 0.49, so ABCL's price volatility has been lower than the market average.

Beta (5Y)	0.49
52-Week Price Change	-34.89%
50-Day Moving Average	2.52
200-Day Moving Average	2.76
Relative Strength Index (RSI)	59.39
Average Volume (20 Days)	4,210,879

Short Selling Information

The latest short interest is 23.62 million, so 7.93% of the outstanding shares have been sold short.

Short Interest	23.62M
Short Previous Month	22.79M
Short % of Shares Out	7.93%
Short % of Float	11.65%
Short Ratio (days to cover)	5.73

Income Statement

In the last 12 months, ABCL had revenue of $28.83 million and -$162.86 million in losses. Loss per share was -$0.55.

Revenue	28.83M
Gross Profit	-138.43M
Operating Income	-282.77M
Pretax Income	-178.81M
Net Income	-162.86M
EBITDA	-223.92M
EBIT	-282.77M
Loss Per Share	-$0.55

Balance Sheet

The company has $625.61 million in cash and $65.36 million in debt, giving a net cash position of $560.25 million or $1.88 per share.

Cash & Cash Equivalents	625.61M
Total Debt	65.36M
Net Cash	560.25M
Net Cash Per Share	$1.88
Equity (Book Value)	1.06B
Book Value Per Share	3.57
Working Capital	674.76M

Cash Flow

In the last 12 months, operating cash flow was -$108.56 million and capital expenditures -$78.40 million, giving a free cash flow of -$186.95 million.

Operating Cash Flow	-108.56M
Capital Expenditures	-78.40M
Free Cash Flow	-186.95M
FCF Per Share	-$0.63

Margins

Gross Margin	n/a
Operating Margin	-980.70%
Pretax Margin	-695.02%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

ABCL does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1.79%
Shareholder Yield	-1.79%
Earnings Yield	-21.02%
FCF Yield	-24.13%

Analyst Forecast

The average price target for ABCL is $7.50, which is 188.46% higher than the current price. The consensus rating is "Buy".

Price Target	$7.50
Price Target Difference	188.46%
Analyst Consensus	Buy
Analyst Count	3
Revenue Growth Forecast (5Y)	20.92%
EPS Growth Forecast (5Y)	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

ABCL has an Altman Z-Score of 2.13 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.13
Piotroski F-Score	2